Faheem Hasnain - 11 Aug 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Director
Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 Aug 2023
Net transactions value
+$299,990
Form type
4
Filing time
14 Aug 2023, 16:41:20 UTC
Previous filing
26 Jul 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Purchase $299,990 +10,791 $27.80 10,791 11 Aug 2023 By Hasnain Revocable Trust Dated 2-19-2010
holding MRTX Common Stock 15,050 11 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.